Capricor therapeutics, inc. (CAPR)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
REVENUE
Collaboration income

-

-

-

-

-

-

-

-

-

-

2,050

2,734

2,962

3,190

3,417

3,645

3,645

3,776

3,906

4,036

4,166

4,166

3,125

2,083

1,041

0

0

0

0

-

1,008

1,354

0

-

0

0

-

-

-

Grant income

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

960

1,005

1,431

1,508

1,501

1,671

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grant income

-

-

-

-

-

-

-

-

-

-

-

-

702

808

797

1,137

1,299

1,741

1,889

1,746

1,366

620

259

80

269

503

2,401

2,321

2,132

1,898

0

0

0

-

0

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL REVENUE

0

-

-

-

0

-

-

-

-

2,666

3,097

3,530

3,664

3,998

4,215

4,783

4,944

5,517

5,796

5,782

5,532

4,786

3,384

2,163

1,311

503

0

0

0

-

1,008

1,354

0

-

0

0

-

-

-

OPERATING EXPENSES
Research and development

4,485

5,141

7,162

9,436

11,181

12,066

11,735

10,466

10,205

10,766

10,913

13,778

14,958

16,042

16,706

15,172

14,291

13,757

13,015

11,790

10,219

7,787

6,881

5,925

5,380

5,197

5,170

4,339

3,360

2,634

2,318

3,609

3,979

4,136

3,943

3,529

0

0

0

General and administrative

3,758

3,597

3,825

4,172

4,518

4,931

5,064

4,894

4,963

4,762

4,679

4,850

5,037

4,933

4,856

4,569

4,061

4,372

3,974

3,821

3,560

3,017

3,015

2,759

2,586

2,208

1,556

1,389

1,338

1,364

1,858

1,960

2,041

2,116

2,261

2,208

0

0

0

TOTAL OPERATING EXPENSES

8,244

8,738

10,987

13,608

15,699

16,998

16,800

15,360

15,168

15,528

15,592

18,628

19,995

20,975

21,563

19,741

18,352

18,129

16,990

15,611

13,780

10,804

9,897

8,685

7,967

7,406

6,727

5,729

4,699

3,998

4,176

5,569

6,021

6,253

6,205

5,737

0

0

0

LOSS FROM OPERATIONS

-7,284

-7,733

-9,556

-12,100

-14,198

-15,327

-15,301

-13,767

-12,983

-12,862

-12,495

-15,097

-16,331

-16,976

-17,348

-14,958

-13,407

-12,611

-11,193

-9,828

-8,247

-6,017

-6,512

-6,521

-6,656

-6,902

-4,520

-3,603

-2,762

-2,100

-3,785

-4,365

-4,471

-4,899

-5,046

-5,391

0

0

0

OTHER INCOME (EXPENSE)
Investment income

79

94

126

141

159

135

101

76

48

38

24

19

8

14

18

13

13

3

0

0

2

1

2

-26

-30

-11

0

0

0

-

-

-

-

-

-

-

-

-

-

Loss on disposal of fixed asset

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

3

4

6

10

15

0

0

0

Interest expense

-

-

-

-

-

-

-

-

-

398

421

412

383

344

305

268

253

248

245

243

236

200

164

128

79

58

33

9

3

0

0

0

0

-

0

-

-

-

-

Impairment of goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

427

428

6

8

6

-4

0

0

0

TOTAL OTHER INCOME (EXPENSE)

0

-

-

-

0

-

-

-

-

15,293

-1,896

-1,892

-1,875

-1,830

-286

-254

-239

-245

-245

-242

-234

-198

-2,081

-2,073

-2,029

-1,989

-446

-385

45

28

430

432

10

14

17

11

0

0

0

NET LOSS

-7,207

-7,641

-9,432

-11,961

-14,038

-15,191

373

1,775

2,426

2,431

-14,391

-16,990

-18,207

-18,806

-17,634

-15,213

-13,647

-12,857

-11,439

-10,071

-8,482

-6,216

-8,593

-8,594

-8,685

-8,891

-4,967

-3,988

-2,716

-2,071

-3,355

-3,933

-4,460

-4,884

-5,029

-5,380

0

0

0

OTHER COMPREHENSIVE INCOME (LOSS)
Net unrealized gain (loss) on marketable securities

0

-13

-20

-18

-20

0

11

10

10

8

7

2

6

-5

-11

-1

7

9

13

7

-3

0

1

32

30

20

0

0

0

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE LOSS

-7,254

-7,654

-9,427

-11,927

-14,027

-15,190

445

1,811

2,437

2,439

-14,384

-16,987

-18,200

-18,812

-17,645

-15,215

-13,640

-12,847

-11,425

-10,063

-8,485

-6,215

-5,804

-5,886

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

COMPREHENSIVE LOSS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Net loss per share, basic and diluted

-0.30

-0.29

-0.43

-0.59

-0.75

-2.26

-1.35

-1.42

-0.14

0.55

-0.12

-0.16

-0.17

-

-0.29

-0.26

-0.26

-0.21

-0.18

-0.19

-0.23

-0.17

-0.13

-0.13

-0.10

-0.40

-0.15

-0.16

-0.14

-0.17

-0.01

-0.01

-0.02

-0.04

-0.03

-0.03

-0.03

-0.05

-0.05

Weighted average number of shares, basic and diluted

6,878

4,293

3,746

3,457

3,347

-21,105

3,060

2,903

26,905

25,860

23,378

22,135

21,399

-

18,286

17,952

16,537

16,273

16,242

16,222

14,869

11,706

11,700

11,692

11,689

10,951

10,351

10,351

10,351

-85,945

43,062

42,951

39,712

-

39,707

35,091

-

-

-

Weighted-average common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,673

34,563

32,285